The CiQC is now CPQA-AQCP & CBQA-PCAB
Tue, 25 Feb 2020

The Canadian Immunohistochemistry Quality Control (CIQC) has transformed from an academic program hosted in the Departments of Pathology at the University of British Columbia and the University of Saskatchewan into two new programs to better reflect the evolving world of biomarker testing in Canadian and international laboratories.

The Canadian Pathology Quality Assurance – Assurance Qualité Canadienne en Pathologie (CPQA-AQCP) is a federal not-for-profit corporation that will focus on routine biomarker testing. To learn more about programs, please visit us at www.cpqa.ca.

Canadian Biomarker Quality Assurance – Programme canadien d’assurance de la qualité des biomarqueurs (CBQA-PCAB) will focus on research, development, and quality assurance of established and emerging predictive/prognostic biomarkers and will also include proficiency testing for pathologists’ biomarker readout. To learn more about programs, please visit us at www.cbqa.ca. CBQA is now the parent program behind the CBQAReadout.ca (formerly CIQCReadout.com). CBQAReadout.ca is an online program for proficiency testing of pathologists’ and technologists’ biomarker readout. As all previous CIQC laboratories are entitled to free access to CBQAReadout.ca, we use this opportunity to share with you the CIQC affiliation code: uMJ6xXTk.
The code will be active until the end of 2020. You will need it at the time of registration at CBQAReadout.ca.

To add to the change there are two new addresses:

CPQA-AQCP
Suite 363
185-9040 Blundell Road Richmond, BC
Canada V6Y 1K3
1-844-822-2472
www.cpqa.ca

CBQA-PCAB/Dr. Emina Torlakovic Pathology, Royal University Hospital 103 Hospital Drive
Saskatoon, SK Canada
S7N 0W8
306-655-1633
www.cbqa.ca

 

Blake Gilks, MD, FRCPC
Chair, CPQA-AQCP

John Garratt, RT (Cyto)
Manager, CPQA-AQCP

Emina Torlakovic, MD, PhD
Director, CBQA-PCAB